Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Economic Impact Of Research Funded By The California Institute For Regenerative Medicine PDF full book. Access full book title Economic Impact Of Research Funded By The California Institute For Regenerative Medicine.
| Author | : Jose Alberro |
| Publisher | : |
| Total Pages | : 25 |
| Release | : 2010 |
| Genre | : Embryonic stem cells |
| ISBN | : |
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 177 |
| Release | : 2013-02-27 |
| Genre | : Medical |
| ISBN | : 0309265932 |
The California Institute for Regenerative Medicine (CIRM) was created in 2005 by The California Stem Cell Research and Cures Act (Proposition 71) to distribute $3 billion in state funds for stem cell research. The passage of Proposition 71 by the voters of California occurred at a time when federal funding for research involving human embryonic stem cells was uncertain, given the ethical questions raised by such research. During its initial period of operations, CIRM has successfully and thoughtfully provided more than $1.3 billion in awards to 59 California institutions, consistent with its stated mission. As it transitions to a broadened portfolio of grants to stimulate progress toward its translational goals, the Institute should obtain cohesive, longitudinal, and integrated advice; restructure its grant application review process; and enhance industry epresentation in aspects of its operations. CIRM's unique governance structure, while seful in its initial stages, might diminish its effectiveness moving forward. The California Institute for Regenerative Medicine: Science, Governance, and the Pursuit of Cures recommends specific steps to enhance CIRM's organization and management, as well as its scientific policies and processes, as it transitions to the critical next stages of its research and development program.
| Author | : Catherine Prescott |
| Publisher | : CRC Press |
| Total Pages | : 408 |
| Release | : 2016-04-19 |
| Genre | : Law |
| ISBN | : 1439836078 |
Now that prohibitions against stem cell research are relaxing, it is time for the field to move forward with the advances that promise to eliminate so much human suffering. However, it would be naive to ignore the fact that regenerative medicines pose a whole new set of challenges to an industry sector that for decades has geared itself to the deve
| Author | : Toni Marzotto |
| Publisher | : CRC Press |
| Total Pages | : 243 |
| Release | : 2017-04-11 |
| Genre | : Medical |
| ISBN | : 1351648985 |
Stem Cell Research takes a multi-disciplinary approach to the topic of human embryonic stem cell research, starting with the breakthrough discovery up through the present day controversy. The book invites the reader to join the conversation by providing a well balanced approach to many of the issues surrounding the development of this controversial scientific field. It includes the thoughts and experiences of scientists, journalists and ethicists as it tried to approach the topic through a variety of different academic disciplines. The book will help the non-scientist understand the biology, research regulations and funding; and simultaneously it will help the scientist better comprehend the full spectrum of ethical, religious, and policy debates.
| Author | : Anthony Atala |
| Publisher | : Academic Press |
| Total Pages | : 607 |
| Release | : 2014-12-01 |
| Genre | : Medical |
| ISBN | : 0124104576 |
Translational Regenerative Medicine is a reference book that outlines the life cycle for effective implementation of discoveries in the dynamic field of regenerative medicine. By addressing science, technology, development, regulatory, manufacturing, intellectual property, investment, financial, and clinical aspects of the field, this work takes a holistic look at the translation of science and disseminates knowledge for practical use of regenerative medicine tools, therapeutics, and diagnostics. Incorporating contributions from leaders in the fields of translational science across academia, industry, and government, this book establishes a more fluid transition for rapid translation of research to enhance human health and well-being. Provides formulaic coverage of the landscape, process development, manufacturing, challenges, evaluation, and regulatory aspects of the most promising regenerative medicine clinical applications Covers clinical aspects of regenerative medicine related to skin, cartilage, tendons, ligaments, joints, bone, fat, muscle, vascular system, hematopoietic /immune system, peripheral nerve, central nervous system, endocrine system, ophthalmic system, auditory system, oral system, respiratory system, cardiac system, renal system, hepatic system, gastrointestinal system, genitourinary system Identifies effective, proven tools and metrics to identify and pursue clinical and commercial regenerative medicine
| Author | : Donald L. Drakeman |
| Publisher | : Oxford University Press |
| Total Pages | : 241 |
| Release | : 2022-02-14 |
| Genre | : Science |
| ISBN | : 0197626300 |
Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
| Author | : Charis Thompson |
| Publisher | : MIT Press |
| Total Pages | : 354 |
| Release | : 2013-12-20 |
| Genre | : Computers |
| ISBN | : 0262026996 |
An examination of a decade and a half of political controversy, ethical debate, and scientific progress in stem cell research. After a decade and a half, human pluripotent stem cell research has been normalized. There may be no consensus on the status of the embryo—only a tacit agreement to disagree—but the debate now takes place in a context in which human stem cell research and related technologies already exist. In this book, Charis Thompson investigates the evolution of the controversy over human pluripotent stem cell research in the United States and proposes a new ethical approach for “good science.” Thompson traces political, ethical, and scientific developments that came together in what she characterizes as a “procurial” framing of innovation, based on concern with procurement of pluripotent cells and cell lines, a pro-cures mandate, and a proliferation of bio-curatorial practices. Thompson describes what she calls the “ethical choreography” that allowed research to go on as the controversy continued. The intense ethical attention led to some important discoveries as scientists attempted to “invent around” ethical roadblocks. Some ethical concerns were highly legible; but others were hard to raise in the dominant procurial framing that allowed government funding for the practice of stem cell research to proceed despite controversy. Thompson broadens the debate to include such related topics as animal and human research subjecthood and altruism. Looking at fifteen years of stem cell debate and discoveries, Thompson argues that good science and good ethics are mutually reinforcing, rather than antithetical, in contemporary biomedicine.
| Author | : United States. Congress. House. Committee on Financial Services |
| Publisher | : |
| Total Pages | : 108 |
| Release | : 2007 |
| Genre | : Economic development |
| ISBN | : |
| Author | : Clive N. Svendsen |
| Publisher | : SAGE Publications |
| Total Pages | : 953 |
| Release | : 2008-08-12 |
| Genre | : Reference |
| ISBN | : 1452265933 |
What is a stem cell? We have a basic working definition, but the way we observe a stem cell function in a dish may not represent how it functions in a living organism. Only this is clear: Stem cells are the engine room of multicelluar organisms—both plants and animals. However, controversies, breakthroughs, and frustration continue to swirl in eternal storms through this rapidly moving area of research. But what does the average person make of all this, and how can an interested scholar probe this vast sea of information? The Encyclopedia of Stem Cell Research provides a clear understanding of the basic concepts in stem cell biology and addresses the politics, ethics, and challenges currently facing the field. While stem cells are exciting alone, they are also clearly fueling the traditional areas of developmental biology and the field of regenerative medicine. These two volumes present more than 320 articles that explore major topics related to the emerging science of stem cell research and therapy. Key Features · Describes the different types of stem cells that have been reported so far and, where possible, tries to explain for each age, tissue, and species what is known about the biology of the cells and their history · Captures a strong sense of stem cell biology as it stands today and provides the reader with a reference manual to probe the mysteries of the field · Considers various religious, legal, and political perspectives · Includes selected reprints of major journal articles that pertain to the milestones achieved in stem cell research · Elucidates stem cell terminology for the nonscientist. Key Themes · Biology · Clinical Trials · Countries · Diseases · Ethics · History and Technology · Industry · Institutions · Legal · Organizations · People · Politics · Religion · States With contributions from scholars and institutional experts in the stem cell and social sciences, this Encyclopedia provides a primarily nonscientific resource to understanding the complexities of stem cell research for academic and public libraries.
| Author | : President's Council on Bioethics (U.S.) |
| Publisher | : |
| Total Pages | : 440 |
| Release | : 2004 |
| Genre | : Bioethics |
| ISBN | : |
